Last updated on March 31, 2023
Brontex tablets are used for loosening phlegm in the case of acute and chronic bronchopulmonary diseases accompanied by productive coughing.
Uses and active ingredients
Composition. The active ingredient is: ambroxol hydrochloride. One tablet contains 30 mg of ambroxol hydrochloride. Excipients are: lactose monohydrate, magnesium stearate, corn starch, colloidal anhydrous silicon dioxide.
Method of Administration
Children aged 6–12 years: ½ tablets 2–3 times per day (30–45 mg of ambroxol per day)
Adults and children above the age of 12: for the first 2–3 days, take 1 tablet 3 times per day (90 mg per day); after that, 1 tablet twice per day (60 mg per day).
You can take up to 60 mg of ambroxol hydrochloride 2 times per day (120 mg per day) if necessary – this can potentially increase the effect of the medicine. The tablets must be taken after a meal.
The phlegm-loosening effect of ambroxol hydrochloride is facilitated by the copious consumption of liquids.
Attention: in the case of a severe renal function disorder, reduce the dose or extend the administration intervals. It is not recommended to use Brontex for longer than 4–5 days, unless prescribed otherwise by your doctor. If your symptoms do not disappear in 4–5 days or are exacerbated, talk to your doctor.
Storage. Do not store at a temperature higher than 25°C/77°F. Keep out of the sight and reach of children. Do not use after the expiry date which is stated on the package. The expiry date refers to the last day of that month.
Warnings
Do not use Brontex tablets if you are allergic to ambroxol or any of the other ingredients of this medicine; if you have a renal function disorder or a severe liver disease. In such cases, caution must be exercised when using ambroxol (administer with longer intervals or in a lower dose). Due to large content of the active substance, the tablets are not suitable for children under the age of 6.
Concomitant use of medicines containing ambroxol with antitussives can lead to a dangerous bronchial mucus obstruction due to the inhibition of the coughing reflex. Increased absorption of the antibiotics amoxicillin, cefuroxim, doxycycline, and erythromycin into bronchial secretion has been reported in connection with the concomitant administration of ambroxol.
The picture is for illustration only. The packaging can be changed by the manufacturer. All packs include English informational leaflet.
